Scientists at Rutgers Health have found a natural molecule made by friendly gut bacteria. It may help the lining of the intestine heal rapidly. It could also protect the body from serious inflammatory diseases.
The molecule is called N-MNA. It raises levels of a substance in the body known as NAD. NAD helps cells make energy. Its levels fall as we age, and many experts believe this drop is a key driver of aging. The study was published in the journal Science Advances.
The team tested N-MNA in mice, fruit flies and human cells. The results suggest it could one day help treat inflammatory bowel disease (IBD) and other long-term gut problems.
Why NAD Is Hard to Boost
NAD cannot enter cells directly. Because of this limitation, scientists have searched for precursors. These are smaller building blocks that cells can absorb and turn into NAD. Some gut bacteria already produce a precursor to NAD, and one specific bacterium that does so is available in dietary supplements. This has created a growing market for products that aim to raise NAD.
N-MNA is almost identical to a molecule that human cells make when they get rid of extra NAD building blocks. But one tiny difference matters. Our version is simply a waste. The bacterial version can be changed back into NAD.
Senior author Nan Gao is a professor at Rutgers New Jersey Medical School. He explained that humans do not seem to make N-MNA, but some bacteria in our gut do. Fellow senior author Xiaoyang Su, of Rutgers Robert Wood Johnson Medical School, said that the small difference between the two molecules allows the bacterial one to turn into NAD.
What the Tests Showed
First author Jiangmeng Han, a doctoral student at Rutgers University-Newark, followed the molecule inside human colon cells. Within 24 hours, it supplied about 22% of the NAD in those cells. It also turned into NAD in human nerve, liver and kidney cells. The same thing happened in fruit flies, in both their bodies and heads.
The animal results were striking. Mice with badly inflamed and damaged colons lost 20% of their body weight and died when left untreated. Mice that received N-MNA injections lost only 5% and recovered. In flies with damaged guts, seven-day survival rose from 43% to 78%. The molecule appears to work by stimulating stem cells, which rebuild injured tissue.
The researchers also studied stool samples from 54 people with IBD and 20 healthy volunteers. Patients with low N-MNA had much higher levels of gut inflammation markers. Gao said that low levels went hand in hand with more inflammation. He added that a stool test might one day show who could benefit from probiotics, although that is probably years away.
Â
What We Still Don’t Know
It is important to stay realistic. The team did not test N-MNA as a treatment in people with IBD. They also did not check whether probiotics that make N-MNA, such as Lactobacilli in yoghurt and supplements, raise NAD in humans.
Ching-On Wong, a senior author and assistant professor at Rutgers-Newark, suggested that N-MNA might be sufficient on its own. However, he cannot rule out that other, better compounds exist.
What Comes Next
The team has won a five-year, $3.6 million grant from the National Institutes of Health. The money will help them find the human enzymes that process N-MNA, which are still unknown. Wong’s lab is testing whether the molecule supports brain-cell health and long life. Gao’s lab is mapping the bacterial genes responsible for producing N-MNA. Rutgers has also filed a provisional patent application covering uses of N-MNA. Gao said the work is at an early stage. His team is still learning the basics of the science.


